Cantitate/Preț
Produs

Human iPSC-derived Disease Models for Drug Discovery: Handbook of Experimental Pharmacology, cartea 281

Editat de Markus H. Kuehn, Wei Zhu
en Limba Engleză Hardback – 24 noi 2023
Since their development a decade ago, human induced pluripotent stem cells (iPSC) have revolutionized the study of human disease, given rise to regenerative medicine technologies, and provided exceptional opportunities for pharmacologic research. These cells provide an essentially unlimited supply of cell types that are difficult to obtain from patients, such as neurons or cardiomyocytes, or are difficult to maintain in primary cell culture. iPSC can be obtained from patients afflicted with a particular disease but, in combination with recently developed gene editing techniques, can also be modified to generate disease models. Moreover, the new techniques of 3 Dimensional printing and materials science facilitate the generation of organoids that can mirror organs under disease conditions. These properties make iPSC powerful tools to study how diseases develop and how they may be treated. In addition, iPSC can also be used to treat conditions in which the target cell population has beenlost and such regenerative approaches hold great promise for currently untreatable diseases, including cardiac failure or photoreceptor degenerations.
Citește tot Restrânge

Din seria Handbook of Experimental Pharmacology

Preț: 90070 lei

Preț vechi: 118514 lei
-24% Nou

Puncte Express: 1351

Preț estimativ în valută:
17238 17905$ 14318£

Carte tipărită la comandă

Livrare economică 30 ianuarie-05 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783031423482
ISBN-10: 3031423488
Pagini: 332
Ilustrații: VIII, 332 p. 100 illus., 30 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:1st ed. 2023
Editura: Springer International Publishing
Colecția Springer
Seria Handbook of Experimental Pharmacology

Locul publicării:Cham, Switzerland

Cuprins

Part 1 General considerations.- Human iPS for clinical applications and cellular products.- 3D-printed iPS disease models.- Part 2 CNS iPSC and organoids.- iPS-derived neurons and brain organoids from patients (brain).- iPS-derived RGCs (eye).- iPS-derived glia (brain).- iPSC to model blood-brain barrier endothelial cells.- Part 3 iPSC-derived nociceptive neurons.- IPSC-based peripheral nerve modeling.- Part 4 Non-neuronal specialized cell types.- iPSC-based drug screening of differentiated cardiomyocyte subtypes.- iPSC-based cardiac disease modeling: from cell to tissue.- iPSC-derived corneal endothelial cell.- iPSC-derived trabecular meshwork (eye).- iPSC for in vitro disease modeling of diabetes.

Caracteristici

Provides an exhaustive review of use of iPSC in pharmaceutics, iPSC-based modeling and materials science Broadens your understanding of iPSC to model diseases of cardiovascular system, nervous system and ophthalmology Presents iPSC-derived disease models that accelerate the development of pharmacologic treatments